InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,705.45
(
-1.86%
)
US TECH 100
19,455.20
(
0.52%
)
Dow Jones
41,763.46
(
-0.90%
)
Brent Oil
74.75
(
0.99%
)
Bitcoin
69,390.81
(
-1.16%
)
Post# of 253503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120650
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tony111 post# 73339

Wednesday, 02/18/2009 5:39:00 PM

Wednesday, February 18, 2009 5:39:00 PM

Post# of 253503

IDIX – I don't think anyone can accurately call the bottom. My feeling is that some hedgies are trying to kill the price now betting IDIX would do a PIPE or secondary by the end of the year.

I agree with your first sentence but not with your second. Based on the CC guidance about cash usage in 2009, I don’t think shorting based on the expectation of a financing deal explains the recent share-price dynamics. However, NVS’ majority stake causes IDIX to have a low float, which makes the stock more volatile than the stocks of most biotech companies with a similar market cap.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up